Jaguar Health (JAGX) Revenue Growth (1y) (2016 - 2026)
Jaguar Health (JAGX) Revenue Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 35.46% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 7.82% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | 19.04% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | 64.03% |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 96.43% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 815.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 815.63% |
| Dec 31, 2025 | -7.81% |
| Sep 30, 2025 | -0.80% |
| Jun 30, 2025 | 9.48% |
| Mar 31, 2025 | -5.83% |
| Dec 31, 2024 | 52.57% |
| Sep 30, 2024 | 10.49% |
| Jun 30, 2024 | 3.58% |
| Mar 31, 2024 | 5,124.44% |
| Dec 31, 2023 | 7,087.50% |
| Sep 30, 2023 | -10.21% |
| Jun 30, 2023 | -10.07% |
| Mar 31, 2023 | 125.00% |
| Dec 31, 2022 | -98.46% |
| Sep 30, 2022 | 409.43% |
| Jun 30, 2022 | 670.71% |
| Mar 31, 2022 | -98.34% |
| Dec 31, 2021 | -19.25% |
| Sep 30, 2021 | 4,630.77% |
| Jun 30, 2021 | 2,607.14% |